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In Diabetes mellitus, long-term complications, that cause morbidity and 
premature mortality, are characterized by microvascular and macrovascular 
diseases. A more frequent concomitant of distal anesthesia is the 
development of neurotropic ulceration, particularly on the plantar aspect of 
the foot. All these events characterize the underlying mechanisms that may 
lead to rapid gangrene after foot injury. Vascular endothelium appears to be 
a vulnerable target for hyperglycemia-induced metabolic changes. 
Activation of polyol pathway, non-enzymatic glycosilation of proteins and 
the increase of reactive oxygen species (ROS) play an important role in 
diabetes complications. 

Ozone has been used as a therapeutical agent and beneficial effects have 
been observed. However, so far only a few biochemical and 
pharmacodynamic mechanisms have been elucidated. We demonstrated 
that controlled ozone administration may promote an oxidative 
preconditioning or adaptation to oxidative stress, preventing the damage 
induced by ROS [1]. Taking into account that diabetes is a disorder 
associated with oxidative stress, we postulate that ozone treatment might 
protect antioxidant systems and maintain, at a physiological level, other 
markers of endothelial cell damage associated with diabetic complications. 

In this study we evaluate ozone efficacy in a preclinical diabetes animal 
model  [2]and in a clinical trial with type 2 diabetes patients suffering of 
diabetic foot complications [3]. 

Diabetes animal model [2]: Five groups of rats were classified as follows: (1) 
control group treated only with physiological saline solution; (2) positive 
control group using streptozotocin (STZ) as a diabetes inductor; (3) ozone 
group, receiving 10 treatments (1.1 mg / kg), one per day after STZ-induced 
diabetes; (4) oxygen group (26 mg /kg), one per day, as in group 3, but 
using oxygen only and (5) control ozone group, as in group 3, but without 
STZ. The following parameters were evaluated: plasma glucose 
concentration; in pancreas homogenates: levels of aldose reductase, 
fructolysine, advanced oxidation protein products, nitrite/nitrates (as an 
index of nitric oxide), glutathione (GSH), total hydroperoxides (TH), 
malondialdehide concentration (MDA), catalase (CAT), superoxide 
dismutase (SOD) and glutathione peroxidase (GSH-Px) activities as 
indicators of redox balance. Pancreas morphology was evaluated by light 
microscopy. 

Clinical assay [3]: Randomized controlled clinical trial where all patients 
provided a signed informed consent before being enrolled was performed. 
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neuroinfectious diabetes foot suffering of ulcers of the feet and lower 
extremities were eligible to participate in the study. These patients must not 
meet any of the following criteria: severe septic conditions, hypersensibility 
to the medication that will be used, hepatic dysfunction, renal failure (serum 
creatinine level > 1.32 mol/L), pregnancy, cancer, current therapy with any 
immunosuppresive agent or anticonvulsant. Patients were randomized to 
two different groups of treatment: 1- control, 50 patients treated with 
antibiotic therapy, systemic and topically in the lesion (during 20 days), and 
2- ozone, 52 patients treated daily with ozone, 20 sessions, by rectal 
insufflation (with an ozone dose of 10 mg, ozone concentration: 40 mg/L) 
and locally. The same biochemical parameters that were taking into account 
in the preclinical study were measured in plasma, at the beginning and at 
the end of the treatments, as well as the clinical evaluation of the lesions 
and length of hospitalization.  

In both studies, ozone treatment improved glycemic control, and prevented 
oxidative stress, the increase of fructolysine content and advanced 
oxidation protein products. However, high plasma glucose figures and 
oxidative stress were maintained in the antibiotic group. In the animal 
model, ozone treatment also improved pancreas integrity. In the clinical 
assay, at the end of the treatments, a decrease of the area and perimeter of 
the lesions, for both groups, was obtained, but the expected total recovery 
showed that patients treated with ozone needed half of the time to achieve 
it, with regard to the antibiotic group. No significant differences between 
both treatments were obtained for the variable clinical evaluation (qualitative 
clinical evaluation), but with a trend to increase the number of cured 
patients and to decrease the non-cured patients in the ozone group, in 
comparison with also decreased the area to be amputated. The length of 
hospitalization decreased in patients treated with ozone with regard to the 
antibiotic group. 

Also, a controlled, randomized and double blind clinical trial was performed 
in 21 patients with a diagnostic criterion of peripheral diabetic neuropathy 
(DN) which were treated with ozone (ozone group) or with oxygen (oxygen 
group), both by rectal insufflation. The results of this study showed that 
repeated administration of ozone in non-toxic doses played a role in the 
control of diabetes and its complications. It is important to emphasize the 
ozone treatment effect in the increase of SOD, as well as to consider it a 
molecular target in this syndrome. This is an interesting explanation, since it 
has been recognized anion superoxide radical as the link of four pathogenic 
pathways associated to micro and macro vascular complications in 
diabetes. 

The ozone treatment, in patients with diabetes type 2 suffering of 
neuroinfectious diabetic foot, improved glycemic control and prevented 
oxidative stress associated to diabetes mellitus and its complications, 
maintaining a cellular redox balance, in agreement with the excellent results 
obtained clinically in these patients. Patients with DN treated with ozone 
showed significant statistical increases in amplitude of peroneal (proximal 
and distal) nerve for both legs and nerve conduction velocity, as well as 
improvement in numbness, paresthesia and painful dysesthesia of the feet. 
However, no significant modification was observed in patients treated with 
oxygen in any of the electrophysiological indicators or clinical symptoms 
measured, between the pre and post treatment values No side effects were 
observed. 

Ozone therapy could be a future alternative in the therapy of diabetes and 
its complications.
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